Financial Performance - Total revenues for Q4 2025 reached $18.666 billion, an increase from $17.361 billion in Q3 2025[4] - Net income attributable to MetLife, Inc. for Q4 2025 was $1.239 billion, compared to $818 million in Q3 2025, reflecting a 51.5% increase[4] - Premiums for Q4 2025 were $12.617 billion, up from $10.555 billion in Q3 2025, representing a 19.5% growth[4] - Net investment income for Q4 2025 was $5.405 billion, an increase from $6.089 billion in Q3 2025[4] - Policyholder benefits and claims for Q4 2025 totaled $12.572 billion, compared to $10.369 billion in Q3 2025, indicating a 21.2% rise[4] - Total expenses for Q4 2025 were $17.285 billion, up from $16.151 billion in Q3 2025[4] - The company reported a net income of $4.426 billion for the full year 2025, compared to $3.379 billion in 2024, marking a 31.0% increase[4] - Adjusted earnings available to common shareholders for Q4 2025 were $1.239 billion, compared to $879 million in Q3 2025[4] Investment Performance - Net investment income for the year ended December 31, 2025, was $22,559 million, compared to $21,273 million in 2024, reflecting an increase of about 6.0%[11] - The company reported net investment gains (losses) of $(1,145) million for the year ended December 31, 2025, compared to $(1,184) million in 2024, showing an improvement in investment performance[11] - Variable investment income included in net investment income for the year ended December 31, 2025, was $1,502 million, up from $1,013 million in 2024, indicating a significant increase of approximately 48.4%[11] - The company reported a net investment loss of $311 million in Q4 2024, compared to a loss of $387 million in Q1 2025[5] - Net investment income including divested businesses for the year ended December 31, 2025 is $21,433 million[57] Assets and Liabilities - Total assets increased from $677,457 million in December 2024 to $745,166 million in December 2025, representing a growth of 10%[19] - Total liabilities increased from $649,754 million in December 2024 to $716,245 million in December 2025, marking an increase of 10%[19] - Policyholder account balances grew from $221,445 million in December 2024 to $236,857 million in December 2025, an increase of 7%[19] - Future policy benefits at the end of December 2025 are projected to be $84,988 million, up from $71,510 million at the end of December 2024, representing a growth of approximately 18.8%[27] Earnings and Shareholder Equity - Adjusted earnings available to common shareholders for the year ended December 31, 2025, were $1,692 million, compared to $1,606 million in 2024, reflecting an increase of 5.4%[22] - Total MetLife, Inc.'s stockholders' equity as of December 31, 2024, was $27,445 million, increasing to $28,398 million by December 31, 2025[76] - Common stockholders' equity rose from $23,627 million on December 31, 2024, to $25,568 million by December 31, 2025[76] - Book value per common share increased from $34.28 on December 31, 2024, to $39.02 by December 31, 2025[76] Segment Performance - Group Benefits segment adjusted earnings increased from $526 million in December 2024 to $589 million in March 2025, a rise of 12%[20] - Asia segment adjusted earnings showed a significant increase from $489 million in June 2025 to $752 million in September 2025, a growth of 54%[20] - Adjusted earnings available to common shareholders in EMEA for December 31, 2024, were $59 million, projected to increase to $97 million by December 31, 2025, representing a growth of 64.4%[44] Expenses - Total adjusted expenses for the year ended December 31, 2025, were $24,739 million, compared to $24,091 million in 2024, reflecting an increase of 2.7%[22] - Adjusted other expenses for the three months ended December 31, 2025, totaled $1,100 million, an increase from $1,041 million in December 2024, reflecting a rise of 5.7%[23] - Employee-related costs for the year ended December 31, 2025, were $3,834 million, an increase from $3,696 million in 2024[18] Future Projections - The company anticipates continued growth in adjusted earnings, with a target of $1,709 million for Q4 2025[5] - The company plans to continue focusing on market expansion and new product development to drive future growth[46] - The company anticipates adjusted premiums, fees, and other revenues to reach $18,614 million for the full year 2025, indicating growth potential[79] Notable Items - Total notable items for the year ended December 31, 2025, included a positive impact of $26 million, while notable items for the year ended December 31, 2024, had a negative impact of $43 million[71] - Total notable items reflect unexpected impacts on MetLife's results, which can affect the company's performance positively or negatively[77]

Core Viewpoint - MetLife reported an increase in fourth-quarter adjusted profit, driven by a stronger return on its investment portfolio [1] Company Summary - The insurer's performance in the fourth quarter was positively impacted by improved returns on investments [1]

Core Viewpoint - MetLife, Inc. is considered one of the best cheap stocks to buy for 2026, despite a recent downgrade by Evercore ISI, which lowered its rating to "In Line" and cut the price target from $108 to $97 [1][3]. Group 1: Analyst Downgrade and Earnings Estimates - Evercore ISI's downgrade was influenced by concerns over potential downside to consensus forward earnings, indicating a weakening of MetLife's earnings expectations compared to previous market anticipations [3]. - The firm reduced its 2026 earnings estimate for MetLife by approximately 3.5% and noted that its initial 2027 earnings estimate was about 4-5% below consensus expectations [3]. Group 2: Valuation and Risk Factors - Analysts expressed valuation concerns, stating that MetLife's stock appears relatively expensive compared to mid-cap peers, although it remains cheaper than some larger competitors [3]. - Specific concerns were raised regarding low new money spreads on public corporate bonds and MetLife's higher risk commercial mortgage loan portfolio compared to peers, which was described as a "double-edged sword" for the stock [4]. Group 3: Growth Opportunities - Despite the risks, MetLife has demonstrated impressive growth in Asia, which could serve as a positive factor for the company [5]. - Analysts noted that risk transfer deals could act as a potential catalyst for MetLife's stock performance [5]. Group 4: Company Overview - MetLife, Inc. provides a range of services including insurance, annuities, employee benefits, and asset management across the United States and international markets, covering life, dental, disability, property, and casualty insurance, as well as retirement and savings products [6].

Core Insights - MetLife, Inc. (MET) is scheduled to report its fourth-quarter 2025 results on February 4, with earnings estimated at $2.36 per share and revenues at $25.6 billion, indicating year-over-year growth of 13.5% and 29.6% respectively [1][5] Financial Performance - The Zacks Consensus Estimate for MetLife's total revenues for the current year is $80 billion, reflecting a 9.4% increase year-over-year, while the EPS estimate stands at $8.71, suggesting a 7.4% rise [2] - In the last four quarters, MetLife missed earnings estimates three times and exceeded them once [2] Earnings Prediction - The current model does not predict a definitive earnings beat for MetLife, as it holds an Earnings ESP of +0.47% and a Zacks Rank of 4 (Sell) [3] Revenue Growth Drivers - The anticipated revenue growth in Q4 is attributed to rising premiums, adjusted group benefits revenues, and adjusted retirement and income solutions revenues, particularly benefiting from international markets in Asia, EMEA, and Latin America [4][5] - The Zacks Consensus Estimate for premiums in the upcoming quarter indicates a significant increase of 79.4% year-over-year [4] Segment Performance - Adjusted retirement and income solutions revenues are projected at $11.3 billion, nearly doubling from the previous year [6] - The Asia segment is expected to benefit from improved variable investment income and increased volumes, while EMEA and Latin America are projected to see growth from higher volumes [6] Challenges - Rising costs and expenses may partially offset profit growth in the upcoming quarter, with a projected decline of 4.1% in adjusted earnings from the Asia business year-over-year [7]

Core Viewpoint - MetLife is expected to report a quarterly earnings per share (EPS) of $2.36, reflecting a 13.5% increase year-over-year, with revenues projected at $25.57 billion, indicating a 29.6% year-over-year growth [1]. Earnings Estimates - The consensus EPS estimate has been revised down by 0.7% in the last 30 days, indicating a reassessment by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3]. Revenue Projections - Analysts predict 'Revenue- Net investment income' to reach $5.50 billion, a year-over-year increase of 1.7% [5]. - 'Revenue- Other Revenues' is estimated at $661.92 million, reflecting a 3.3% year-over-year increase [5]. - 'Revenue- Universal life and investment-type product policy fees' is projected at $1.26 billion, indicating a 3.4% year-over-year growth [5]. Adjusted Revenue Estimates - 'Adjusted Revenue- Group Benefits- Other Revenues' is expected to be $404.67 million, a 7.1% increase from the previous year [6]. - 'Total Adjusted Revenue- EMEA' is forecasted at $782.70 million, representing a 10.1% year-over-year change [6]. - 'Adjusted Revenue- Asia- Universal life and investment-type product policy fees' is estimated at $398.66 million, showing a decline of 2.8% from the prior year [7]. - 'Adjusted Revenue- Latin America- Universal life and investment-type product policy fees' is projected to reach $367.09 million, reflecting an 11.2% increase [7]. Regional Revenue Insights - 'Adjusted Revenue- EMEA- Universal life and investment-type product policy fees' is expected to be $82.90 million, indicating a 9.1% year-over-year increase [8]. - 'Total Adjusted Revenue- Asia' is projected at $3.03 billion, reflecting a 5.1% increase from the previous year [8]. - 'Adjusted Revenue- Asia- Net investment income' is expected to reach $1.38 billion, indicating a 10.5% year-over-year growth [9]. - 'Adjusted Revenue- EMEA- Net investment income' is projected at $63.95 million, reflecting an 8.4% increase [9]. - 'Adjusted Revenue- Latin America- Net investment income' is estimated at $428.82 million, indicating a decline of 0.5% from the prior year [10]. Stock Performance - MetLife shares have decreased by 0.9% over the past month, contrasting with the S&P 500 composite's increase of 0.9%, and the company holds a Zacks Rank 4 (Sell), suggesting expected underperformance in the near term [11].

Group 1 - In 2026, a significant amount of residential fixed deposits, estimated to exceed 50 trillion yuan, will mature, leading banks to promote insurance products, particularly dividend and annuity insurance, as key investment options during the "opening red" period [1] - Insurance products are gaining popularity among customers due to their competitive annualized interest rates, which can reach over 3%, depending on market conditions [1][2] - The sales of insurance products, especially during the "opening red" period, are experiencing high demand, with some products facing tight quotas, particularly those with higher returns [2] Group 2 - Dividend and annuity insurance products are characterized by a certain lock-in period, typically requiring at least two years before withdrawals can be made, making them long-term investment options [3] - Dividend insurance generally offers higher returns compared to annuity insurance, while annuity insurance is more suitable for clients with cash flow needs [3] - The safety of principal is generally assured as long as clients do not withdraw funds during the lock-in period, with fixed-term returns expected [3]

Group 1 - The article does not provide any relevant content regarding the company or industry [1]

Core Insights - MetLife Investment Management completed the acquisition of PineBridge Investments LLC from the Pacific Century Group, originally announced in December 2024 and valued at $1.2 billion [2][3] Group 1: Acquisition Details - The transaction involved $800 million in cash and two conditional payments of $200 million each [3] - The combined business will manage total assets of approximately $735 billion [3] - PineBridge's private equity funds group and its joint venture in China were excluded from the deal [4] Group 2: Strategic Implications - The acquisition enhances MetLife Investment Management's institutional strength and scale by leveraging PineBridge's global expertise [4] - This move aligns with MetLife Inc.'s New Frontier strategy, a five-year plan introduced in December 2024 [4] Group 3: Leadership and Future Outlook - Brian Funk will lead the combined entity, with a new senior leadership team announced [5][6] - MetLife's CFO John McCallion emphasized that the combined capabilities will drive future growth and success [5]

Group 1 - The core viewpoint of the article is that MetLife Investment Management (MIM), a subsidiary of MetLife, has completed the acquisition of Barings, enhancing MIM's position as a leading global multi-asset management firm [1] - The combined assets under management of MIM and Barings now total $734.7 billion, indicating significant scale in the asset management industry [1] - The acquisition leverages MIM's institutional investment strength and scale alongside Barings' global reach and specialized services, further solidifying MIM's competitive edge [1]

Core Viewpoint - MetLife Investment Management has successfully acquired PineBridge Investments, enhancing its asset management capabilities and aligning with its New Frontier strategy to accelerate growth in this sector [1] Group 1: Acquisition Details - The acquisition of PineBridge Investments allows MetLife to combine its institutional strength and scale with PineBridge's global reach [1] - The combined entity will manage a total of $734.7 billion in assets, serving clients worldwide [1]